Imbruvica140 mg Capsules :120 Capsules per Bottle

Description

Product introduction

• Imbruvica® 140 mg Capsules contain ibrutinib, a targeted therapy that inhibits Bruton’s tyrosine kinase (BTK), a protein involved in B-cell receptor signaling and the growth and survival of certain malignant B cells.By blocking BTK signaling, ibrutinib can interfere with pathways that contribute to the proliferation and survival of abnormal B cells. Imbruvica is used for specific hematologic malignancies and lymphoid cancers according to approved indications and the patient’s clinical condition.

  Treatment with Imbruvica should be initiated and monitored by an experienced oncology or hematology specialist. The appropriate dose and duration of treatment depend on the specific indication, patient characteristics, concomitant medicines, and clinical response.

  Product Introduction

  Imbruvica® 140 mg Capsules are an oral targeted cancer therapy containing ibrutinib. The medicine is used for specific B-cell malignancies and other approved hematologic cancers.

  Uses of Imbruvica®

  • Used in the treatment of certain B-cell blood cancers.
  • May be prescribed for specific types of chronic lymphocytic leukemia (CLL).
  • Used for certain small lymphocytic lymphoma (SLL) cases.
  • May be used for Waldenström’s macroglobulinemia (WM).
  • May be prescribed for other approved hematologic malignancies depending on the patient’s condition and applicable treatment guidelines.

  Benefits of Imbruvica® in Treatment

  • Provides targeted inhibition of the BTK signaling pathway.
  • Helps interfere with the growth and survival of certain abnormal B cells.
  • Provides an oral treatment option for eligible patients.
  • Can be incorporated into specialist-directed treatment plans for specific hematologic malignancies.

  Side Effects of Imbruvica®

  Possible side effects may include:

  • Diarrhea
  • Fatigue
  • Muscle or joint pain
  • Nausea
  • Bruising
  • Rash
  • Upper respiratory tract infections
  • Headache

  More serious reactions can occur, including bleeding, infections, cardiac rhythm problems, hypertension, and other clinically significant effects. Patients should discuss any persistent or serious symptoms with their healthcare professional.

  Quick Tips

  • Take Imbruvica exactly as prescribed by your oncologist or hematologist.
  • Swallow the capsule whole with water; do not open, crush, or chew it.
  • Take the medicine at approximately the same time each day.
  • Do not change the dose or discontinue treatment without medical advice.
  • Tell your doctor about all medicines, supplements, and herbal products you are taking because ibrutinib can interact with other medicines.
  • Inform your healthcare professional before surgery or invasive procedures.
  • Seek immediate medical attention for unusual or severe bleeding, signs of infection, chest pain, severe dizziness, or other serious symptoms.

To Order

oder@srkpharma.com